MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy.
BACKGROUND:Rett Syndrome (RTT) is an Autism Spectrum Disorder and the leading cause of mental retardation in females. RTT is caused by mutations in the Methyl CpG-Binding Protein-2 (MECP2) gene and has no treatment. Our objective is to develop viral vectors for MECP2 gene transfer into Neural Stem C...
Main Authors: | Mojgan Rastegar, Akitsu Hotta, Peter Pasceri, Maisam Makarem, Aaron Y L Cheung, Shauna Elliott, Katya J Park, Megumi Adachi, Frederick S Jones, Ian D Clarke, Peter Dirks, James Ellis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-08-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2728539?pdf=render |
Similar Items
-
MECP2e1 isoform mutation affects the form and function of neurons derived from Rett syndrome patient iPS cells
by: Ugljesa Djuric, et al.
Published: (2015-04-01) -
Linking Epigenetics to Human Disease and Rett Syndrome: The Emerging Novel and Challenging Concepts in MeCP2 Research
by: Robby Mathew Zachariah, et al.
Published: (2012-01-01) -
Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease
by: Shervin Pejhan, et al.
Published: (2021-01-01) -
MECP2 Mutations and Rett Syndrome Phenotypes
by: J Gordon Millichap
Published: (2000-05-01) -
Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements.
by: Carl O Olson, et al.
Published: (2014-01-01)